CRL · 10-Q · 2026Q2 · Full report

Products and Technology

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 26 · Surprise 24

Charles River’s Microbial Solutions business saw increased demand for endotoxin products during the quarter and first six months of 2026. The business provides in vitro lot-release testing products, microbial detection products, and species-identification services for pharmaceutical and other life-science customers. Endotoxin product growth partially offset revenue lost from the divestiture of the CDMO business.

Key facts

• Manufacturing revenue increase in Microbial Solutions was driven primarily by higher endotoxin product revenue. source